We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.1B
AUM Growth
+$989M
(+9.8%)
Cap. Flow
+$432M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,372
New
66
Increased
556
Reduced
543
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$45.7M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Eli Lilly
LLY
|
+$32.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.6M |
| 2 |
Oracle
ORCL
|
+$40M |
| 3 |
Equity Residential
EQR
|
+$34.6M |
| 4 |
Citigroup
C
|
+$31.3M |
| 5 |
ExxonMobil
XOM
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.49% |
| 2 | Technology | 14.87% |
| 3 | Financials | 14.25% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Nike
NKE
$64.2B
| $22.5M | 0.2% |
404,164
+111,070
| +38% | +$6.14M |
|
127
Criteo
CRTO
$1.13B
| $22.2M | 0.2% |
443,857
+129,002
| +41% | +$6.03M |
|
|
MRSH
128
Marsh
MRSH
$93.9B
| $21.9M | 0.2% |
296,043
+159,588
| +117% | +$11.4M |
|
|
FISV
129
Fiserv Inc
FISV
$29.6B
| $21.8M | 0.2% |
377,968
-129,018
| -25% | -$7.24M |
|
130
Entergy
ETR
$50.4B
| $21.3M | 0.19% |
561,174
-178,560
| -24% | -$6.54M |
|
131
Halliburton
HAL
$26B
| $21.3M | 0.19% |
431,824
+132,352
| +44% | +$7.12M |
|
132
AerCap
AER
$23.5B
| $21M | 0.19% |
457,671
+40,743
| +10% | +$1.82M |
|
133
Starbucks
SBUX
$118B
| $21M | 0.19% |
359,334
+189,150
| +111% | +$10.7M |
|
134
Quest Diagnostics
DGX
$25.9B
| $20.9M | 0.19% |
212,842
+96,778
| +83% | +$9.23M |
|
135
Public Storage
PSA
$61.4B
| $20.8M | 0.19% |
95,069
-39,220
| -29% | -$8.69M |
|
|
SLCA
136
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $20.6M | 0.19% |
430,091
+209,201
| +95% | +$11.2M |
|
137
Delta Air Lines
DAL
$56.8B
| $20.5M | 0.19% |
446,495
+338,598
| +314% | +$16.5M |
|
|
AET
138
DELISTED
Aetna Inc
AET
| $20.2M | 0.18% |
158,392
+20,225
| +15% | +$2.54M |
|
139
AvalonBay Communities
AVB
$27.5B
| $20.1M | 0.18% |
109,745
-36,122
| -25% | -$6.48M |
|
140
Goldman Sachs
GS
$289B
| $20M | 0.18% |
87,066
-23,587
| -21% | -$5.7M |
|
141
Tyson Foods
TSN
$21.5B
| $19.9M | 0.18% |
322,256
-44,398
| -12% | -$2.8M |
|
142
CME Group
CME
$95.4B
| $19.9M | 0.18% |
167,089
+42,217
| +34% | +$5.08M |
|
143
Best Buy
BBY
$19B
| $19.6M | 0.18% |
399,637
+168,837
| +73% | +$7.54M |
|
144
Incyte
INCY
$25.4B
| $19.6M | 0.18% |
146,350
+85,983
| +142% | +$10.9M |
|
|
DFS
145
DELISTED
Discover Financial Services
DFS
| $19.5M | 0.18% |
285,761
+69,717
| +32% | +$4.89M |
|
146
Ameriprise Financial
AMP
$47.8B
| $19.3M | 0.17% |
149,043
-15,342
| -9% | -$1.9M |
|
147
Blackrock
BLK
$168B
| $19.3M | 0.17% |
50,282
+13,065
| +35% | +$5M |
|
148
Ametek
AME
$54.1B
| $19.2M | 0.17% |
355,706
+57,852
| +19% | +$3.05M |
|
149
Synchrony
SYF
$24.4B
| $18.8M | 0.17% |
546,955
+173,625
| +47% | +$6.23M |
|
|
CDK
150
DELISTED
CDK Global, Inc.
CDK
| $18.6M | 0.17% |
285,590
+188,226
| +193% | +$12.1M |
|
Similar funds
HF
KBC Group's Q1 2017 Portfolio in Review
As of Q1 2017, KBC Group held 1,372 positions worth $11.1B, up 9.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group deployed $432M of net new capital in Q1 2017, opening 66 new positions and adding to 556 existing holdings. Its largest new stake was LogMein, Inc.: 156,863 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $51.6M trimmed.
- KBC Group's largest Q1 2017 buy was LogMein, Inc.: 156,863 shares worth $15.3M.
- KBC Group added most to Microsoft in Q1 2017, an estimated $45.7M increase.
- KBC Group's biggest Q1 2017 reduction was Pfizer, cutting an estimated $51.6M.
- KBC Group fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $16.2M.
- KBC Group's ten largest holdings make up 15% of its $11.1B portfolio in Q1 2017.
- KBC Group opened 66 new positions and closed 69 in Q1 2017.
- KBC Group's portfolio value rose 9.8% quarter-over-quarter to $11.1B.
Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.